medigraphic.com
ISSN 2305-7939 (Electronic)

2017, Number 2

<< Back Next >>

RCU 2017; 6 (2)

Amyloidosis as bladder tumour

Leyva YW, Pupo RA, Grass HN, Santamaría PY

Language: Spanish
References: 11
Page: 100-105
PDF size: 546.23 Kb.


ABSTRACT

Introduction: The gross haematuria in adults, make consider tumour´s diagnostics. Approximately 90 % of all bladder tumours are transitional cell carcinomas. Objective: Present an interest and infrecuent case of amyloidosis genitourinary location. Case presentation: We present a male 48 years with the only gross haematuria symtom. On physical exam were not found positive sings. Laboratory test positive only report gross haematuria. The ecographic study describe an ecogenic bladder´s mass as a tumour, described too by cistoscopy. Were practiced partial cystectomy with good evolution. Histologic diagnostic revealed bladder amyloidosis, an infrecuent diagnosis. The therapeutics options are reasons of discussion and there is not an estandar model, but is clear that vesical´s damages is an indication to surgical remove. Followed for two year the patient is free of amyloidosis´s symtoms and sings vesicals and in others parts of body. Conclusion: We most remeber the benign forms of bladder tumour.


REFERENCES

  1. Sipe JD, Benson MD, Buxbaum JN, Ikeda S, Merlini G, Saraiva MJ, et al. Amyloidfibril protein nomenclature 2012: recommendations from the Nomenclature Committee of the International Society of Amyloidosis. Amyloid. 2012 [citado 05 Jul 2017];19(4):[aprox. 5 p.]. Disponible en: http://www.tandfonline.com/doi/abs/10.3109/ 13506129.2012.734345

  2. Zhou F, Lee P, Zhou M, Melamed J, Ming Deng F. Primary localized amyloidosis of the urinary tract frequently mimics neoplasia: a clinic pathologic analysis of 11 cases. Am J ClinExpUrol. 2014 [citado 05 Jul 2017];2(1):[aprox. 7 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PM C4219293/

  3. Akram CM, Al‐Marhoon EM, Mathew J, Grant CS, Rao TV. Primarylocalized AA typeamyloidosis of urinarybladder: Case report of rare cause of episodicpainless hematuria. Urology. 2006 [citado 05 Jul 2017];68(6):[aprox. 3 p.]. Disponible en: http://www.sciencedirect.com/science/article/ pii/S0090429506022515

  4. Sipe JD, Benson MD, Buxbaum JN, Ikeda S, Merlini G, Saraiva MJ, et al. Nomenclature 2014: amyloidfibrilproteins and clinical classification of theamyloidosis. Amyloid. 2014 [citado 05 Jul 2017];21(4):[aprox. 4 p.]. Disponible en: http://www.tandfonline.com/doi/abs/10.3109/ 13506129.2014.964858

  5. Gupta P, Hanamshetti S, KulkarniJN. Primaryamyloidosiswithhigh grade transitionalcell carcinoma of bladder: a rare case report. J Cancer Res Ther. 2012 [citado 05 Jul 2017];8(2):[aprox. 7 p.]. Disponible en: http://www.cancerjournal.net/article.asp?issn= 0973‐ 1482;year=2012;volume=8;issue=2;spage=297; epage=299;aulast=Gupta

  6. Hosseini A, Ploumidis A, Adding C, Wiklund NP. Radical surgeryfortreatment of primarylocalizedbladderamyloidosis: couldprostate‐sparing robotassistedcystectomywithintracorporealurinarydi version be anoption? Scand J Urol. 2013 [citado 05 Jul 2017];47(1):[aprox. 3 p.]. Disponible en: http://www.tandfonline.com/doi/abs/10.3109/ 00365599.2012.693539

  7. Montagna G, Cazzulani B, Obici L. Benefit of doxycyclinetreatmenton articular disabilitycausedbydialysisrelatedamyloidosis. Amyloid. 2013 [citado 05 Jul 2017];20(3):[aprox. 5 p.]. Disponible en: http://www.tandfonline.com/doi/abs/10.3109/ 13506129.2013.803463

  8. Sultan A, Raman B, Rao C, Tangirala R. The extra celular chaperonehaptoglobin prevents serumfattyacid ‐ promotedamyloidfibrilformation of beta 2‐ microglobulin, resistancetolysosomaldegradation, and cytotoxicity. J BiolChem. 2013 [citado 05 Jul 2017];288( 45):[aprox. 18 p.]. Disponible en: http://www.jbc.org/content/288/45/32326.sho rt

  9. Jadoul M, Drüeke TB. β 2 microglobulinamyloidosis: anupdate 30 yearslater. Nephrol Dial Transplant. 2016 [citado 05 Jul 2017];31(4):[aprox. 5 p.]. Disponible en: https://academic.oup.com/ndt/article/31/4/50 7/2460060/2‐microglobulin‐amyloidosis‐anupdate‐ 30‐years

  10. Nienhuis HLA, Bijzet J, Hazenberg BPC. The Prevalence and Management of Systemic Amyloidosis in Western Countries. KidneyDis. 2016 [citado 05 Jul 2017];2:[aprox. 10 p.]. Disponible en: https://www.karger.com/Article/PDF/444206

  11. Cedeño Yera ED, García García A, Matos Lovaina E, Cruz Álvarez M, Chong López A, Fernández Arias MA. A propósito de un caso de amiloidosis vesical. Rev.Cub.Med. 2014 [citado 05 Jul 2017];53(2):[aprox. 7 p.]. Disponible en: http://scieloprueba.sld.cu/pdf/med/v53n2/me d11214.pdf




2020     |     www.medigraphic.com